Literature DB >> 10874593

Characterization of protease-activated receptors in rat peritoneal mast cells.

H Nishikawa1, A Kawabata, R Kuroda, M Nishida, K Kawai.   

Abstract

Activation of protease-activated receptor (PAR)-1 or PAR-2 elicits inflammation most probably via mast cell degranulation in vivo. The present study aimed at characterizing PARs in rat peritoneal mast cells (PMC). Messenger RNA for PAR-1, but not for PAR-2, was detected in PMC. Thrombin, the PAR-1 agonist SFLLR-NH2 or the PAR-2 agonist SLIGRL-NH2 failed to induce histamine release from PMC. Surprisingly, the PAR-2-inactive control peptide LSIGRL-NH2 triggered histamine release from PMC. Thus, PAR-1, but not PAR-2, are expressed in PMC, whereas neither PAR-1 nor PAR-2 are considered to be involved in degranulation of PMC. LSIGRL-NH2 does not appear to be appropriate as a control peptide for PAR-2 in inflammation studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874593     DOI: 10.1254/jjp.82.74

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species.

Authors:  Wei Han; Xuefeng Lu; Xiaoqing Jia; Tao Zhou; Chenghao Guo
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

2.  Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation.

Authors:  Ricardo Saban; Cindy Simpson; Carole A Davis; Igor Dozmorov; Julie Maier; Ben Fowler; Michael A Ihnat; Robert E Hurst; Barry K Wershil; Marcia R Saban
Journal:  BMC Immunol       Date:  2007-08-17       Impact factor: 3.615

3.  A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation.

Authors:  Hashem N Alshurafa; Grant R Stenton; John L Wallace; Morley D Hollenberg; A Dean Befus; Harissios Vliagoftis
Journal:  BMC Pharmacol       Date:  2004-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.